MATTHEW CULLEN;BRADLEY TAIT;PROTEOSTASIS THERAPEUTICS INC.
发明人:
BRADLEY TAIT,MATTHEW CULLEN
申请号：
IL24336015
公开号：
IL243360D0
申请日:
2015.12.27
申请国别(地区):
IL
年份:
2016
代理人:
摘要：
The invention encompasses methods of modulating CFTR activity in a subject in need thereof comprising administering an effective amount of a compound of Formula (I). The invention also encompasses methods of treating a condition associated with CFTR activity or condition associated with a dysfunction of proteostasis comprising administering to a subject an effective amount of a compound of Formula (I).
